捷豹健康将主持2025年第四季度业绩网络直播。 Jaguar Health to host webcast for Q4 2025 results.

捷豹健康宣布将于2026年4月10日星期五上午8：30（东部时间）举办投资者网络直播，讨论其2025年第四季度财务业绩及公司动态。 Jaguar Health announced it will host an investor webcast on Friday, April 10, 2026, at 8:30 a.m. Eastern Time, to discuss its fourth-quarter 2025 financial results and company updates. 网络广播将涵盖其整个产品组合的发展,包括子公司Napo Pharmaceuticals和Napo Therapeutics S.p.A.,专注于罕见胃肠道疾病中的crofelemer以及植物性精神健康治疗的联合企业Magdalena Biosciences. The webcast will cover developments across its portfolio, including subsidiaries Napo Pharmaceuticals and Napo Therapeutics S.p.A., which focus on crofelemer for rare gastrointestinal disorders, and the joint venture Magdalena Biosciences for plant-derived mental health treatments. 投资者关系网站上将提供重播. A replay will be available on its investor relations website.